Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Donor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00001830
What this trial is testing

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHodgkin's Disease+2 more
National Cancer Institute (NCI) 110
Testing effectiveness (Phase 2)Ended earlyNCT01624701
What this trial is testing

Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells

Who this might be right for
Acute LeukemiaChronic LeukemiaMyelodysplastic Syndrome+2 more
Singapore General Hospital 3
Not applicableStudy completedNCT02274064
What this trial is testing

Motivating Type O- Blood Donors to Return

Who this might be right for
Blood Donors
Ohio University 598
Testing effectiveness (Phase 2)Study completedNCT03413800
What this trial is testing

Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant

Who this might be right for
Relapsed Hematologic MalignancyMultiple Myeloma
Ciusss de L'Est de l'Île de Montréal 10
Not applicableUnknownNCT04413721
What this trial is testing

Effects of Packed Red Blood Cell Storage Duration on Pediatric Living Donor Liver Transplantation

Who this might be right for
Transfusion Related Complication
RenJi Hospital 360
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Post-approval studies (Phase 4)WithdrawnNCT03026023
What this trial is testing

Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac Transplant

Who this might be right for
Cardiac Transplant DisorderHepatitis C
Raymond T. Chung, MD
Not applicableUnknownNCT06021925
What this trial is testing

Obstetrical History and Anti-HLA Antibodies Level

Who this might be right for
Blood DonorsAnti-HLA Antibody
Assistance Publique - Hôpitaux de Paris 6,000
Not applicableStudy completedNCT02646059
What this trial is testing

The Effective Ways of Recruiting Lapsed Blood Donors: a Stratified Randomized Pilot Study

Who this might be right for
Blood Donor
Guangzhou Blood Center 1,188
Not applicableStudy completedNCT03835299
What this trial is testing

Addressing Fear and Risk of Vasovagal Reactions Among High School Donors

Who this might be right for
Blood Donors
Ohio University 4,035
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT05678647
What this trial is testing

Sucrosomial Iron and Iron Sulphate to Blood Donors

Who this might be right for
Blood Donation
Uppsala University Hospital 120
Not applicableStudy completedNCT02655055
What this trial is testing

Bone Density in Voluntary Apheresis Blood Donors

Who this might be right for
Bone Density
Versiti Blood Health 58
Early research (Phase 1)WithdrawnNCT03531281
What this trial is testing

Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHematopoietic Cell Transplantation Recipient
City of Hope Medical Center
Early research (Phase 1)Study completedNCT02560220
What this trial is testing

MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients

Who this might be right for
Kidney Failure, Chronic
Heidelberg University 14
Testing effectiveness (Phase 2)Ended earlyNCT00531310
What this trial is testing

Reduced Intensity AlloSCT in(CML) With Persistent Disease

Who this might be right for
Chronic Myeloid Leukemia
Columbia University 5
Post-approval studies (Phase 4)Looking for participantsNCT06840756
What this trial is testing

Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes

Who this might be right for
Red Blood Cell TransfusionsSex DifferencesHealth Services+3 more
Michelle Zeller 11,082
Not applicableStudy completedNCT02322151
What this trial is testing

Pharmacokinetics of Granulocyte Colony Stimulating Factor in the Breast Milk of Volunteer Peripheral Blood Stem Cell Donor

Who this might be right for
Normal Physiology
National Institutes of Health Clinical Center (CC) 4
Not applicableActive Not RecruitingNCT04277377
What this trial is testing

Nanoparticle for DSA Removal

Who this might be right for
Kidney FailurePresence of Donor Specific Antibodies
University of Zurich 100
Next Page